Sunday, Nov. 22, 2026 A Vik Media Group publication
Mongevity Longevity in Motion
Leer en español

Women’s cancers: PARP pills delay ovarian cancer’s return, with more side effects

☕ Includes a question for the family ↓

Breast, ovarian and uterine cancerPart of a story we are following · 11 articles · See every update
A woman with curly hair holds a warm drink in a bright indoor room.
A woman with curly hair holds a warm drink in a bright indoor room.Photo: Shixart1985 / Wikimedia Commons, CC BY 2.0

If you follow news about women’s cancers, here is a useful update on ovarian cancer. A large review shows that a group of pills called PARP inhibitors can give many women a much longer stretch without their cancer growing. It also shows that those pills come with more serious side effects, and that is worth knowing too.

In a review of 24 trials with 8,961 women with epithelial ovarian cancer, PARP inhibitor pills taken after chemotherapy kept the cancer from growing for much longer, and they also brought more severe side effects. Quality of life did not seem to change much.

How the study worked

This was a meta-analysis, which means the researchers gathered and combined the results of many randomized trials. They pooled 24 trials covering 8,961 women, some newly diagnosed with advanced epithelial ovarian cancer and some whose cancer had come back. It was published in the Cochrane Database of Systematic Reviews on November 11, 2026. One limit: the trials often reported side effects and patient-reported experience in thin detail.

What are PARP inhibitors?

Cancer cells, like all cells, get DNA damage and need to repair it. PARP inhibitors block one of the repair tools the cancer cells use. This works especially well in cancers with changes in genes called BRCA. It is a different approach from standard chemotherapy. Most women in these trials had BRCA changes or a related repair problem in their tumors.

What they found

The clearest result came from women who took a PARP pill as “maintenance” after chemotherapy. Maintenance means a pill taken to keep the cancer in check once chemo is done.

  • Newly diagnosed advanced cancer: The pills gave a large improvement in how long women went without the cancer growing, no matter which PARP pill they took.
  • Cancer that came back and still responded to platinum chemotherapy: The same pattern held, with an even bigger gain in time without growth.

Living longer overall showed a smaller gain, and the results were less certain. One reason is that many women in the comparison groups later got a PARP pill themselves after their cancer returned, which blurs the picture.

The tradeoff is side effects. In newly diagnosed women, severe side effects were more than twice as likely with the pills (2.66 times as likely). In women whose cancer had returned, they were about three times as likely (3.03 times). Even so, women’s quality of life did not change much. In the recurrent group, the studies found little to no difference.

The pills did not help in other situations:

  • Pill alone versus chemotherapy: In women whose cancer had come back and still responded to platinum drugs, overall survival was about the same.
  • Cancer that no longer responded to platinum chemotherapy: Women lived less long on the pill alone than on chemotherapy.

So these pills are not a fit for everyone. They work best as a follow-up after chemotherapy, in the right situation.

Why does the timing of side effects matter?

The review points out something many people miss. Maintenance pills are taken at a time when a woman would otherwise be off treatment. That is why the extra side effects matter, and why quality of life is part of the decision, not an afterthought. The researchers also say good information on side effects is crucial for patients making choices.

What you can do today

If you or someone you love is facing this decision, take five minutes to write down three questions for the care team: which side effects are most likely, what can be done to ease them, and how the team will check how you are feeling along the way. Bring the list to the next appointment.

Talk about it at home

Our cells are always copying their instruction book, and little typos sneak in, so the body has tiny repair crews that fix them, a bit like a proofreader who catches mistakes in a copied recipe. To learn what works, scientists did not trust studies that stood alone. They gathered the results of many studies and added them together, the way you would trust a recipe more after many different kitchens had tried it.

Question for the table

Write a silly sentence on a slip of paper and pass it around the table, with each person copying the copy before it, never looking at the original. Then lay the original next to the last copy and hunt for the little changes that crept in. Who wants to be the proofreader?

Keep exploring

Copies this article and its questions so you can paste them into ChatGPT, Claude, Gemini or the AI you use, and keep the conversation going.

Got a question? Ask us ›

Get the best of longevity science by emailThe most useful new studies, in plain language and with the source. Free.

We'll email you once to confirm. Occasional messages from our sponsors, clearly labeled. Unsubscribe anytime. We never ask for health data.
Cite this article
AMA
Mongevity Desk. Women’s cancers: PARP pills delay ovarian cancer’s return, with more side effects. Mongevity. Published November 11, 2026. Accessed November 22, 2026. https://mongevity.science/cancer/2026/11/parp-inhibitors-ovarian-cancer-review/
Vancouver
Mongevity Desk. Women’s cancers: PARP pills delay ovarian cancer’s return, with more side effects [Internet]. Mongevity; 2026 Nov 11 cited 2026 Nov 22]. Available from: https://mongevity.science/cancer/2026/11/parp-inhibitors-ovarian-cancer-review/
APA
Mongevity Desk. (2026, November 11). Women’s cancers: PARP pills delay ovarian cancer’s return, with more side effects. Mongevity. https://mongevity.science/cancer/2026/11/parp-inhibitors-ovarian-cancer-review/
For your website
<a href="https://mongevity.science/cancer/2026/11/parp-inhibitors-ovarian-cancer-review/">Women’s cancers: PARP pills delay ovarian cancer’s return, with more side effects</a>

Free to share or quote with credit and a link.

Questions and answers

What are PARP inhibitors?
They are pills that block a tool cancer cells use to repair their DNA. They work especially well in cancers with BRCA gene changes.
Do PARP pills help women with ovarian cancer live longer?
They clearly lengthened the time before the cancer grew again. The gain in overall survival was smaller and less certain.
Do the pills hurt quality of life?
Quality of life did not change much in the studies, even though severe side effects were more common.
Do PARP pills work for every situation?
No. The best results came when they were taken after chemotherapy. In cancer that no longer responded to platinum chemotherapy, women lived less long on the pill alone than on chemotherapy.

Sources

  1. Cochrane Database Syst Rev: Poly (ADP-ribose) polymerase inhibitors (PARPi) for treating advanced epithelial ovarian cancer (PMID 43012369 · DOI 10.1002/14651858.cd007929.pub5) · 2026-11-11

More on this story

Report an error